Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00486265
Status:
TERMINATED
Last Update Posted:
2010-12-21
First Post:
2007-06-13
Brief Title:
Phase III Open-label Multi-center Two Part Dose-escalation Safety Pharmacokinetics PK and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia AML
Sponsor:
Organization:
AstraZeneca